Information Provided By: 
Fly News Breaks for January 23, 2020
NEO
Jan 23, 2020 | 05:21 EDT
First Analysis analyst Joseph Munda downgraded NeoGenomics to Outperform from Strong Buy with a price target of $35, up from $29. The analyst remains positive on the shares after meeting with management but downgraded the shares due to valuation. He feels the 41% appreciation since the company's Q3 earning report prices in much of the short-term potential. However, NeoGenomics remains one of Munda's favorite long-term names.
News For NEO From the Last 2 Days
There are no results for your query NEO
